18+ · Research Use Only · Not for Human Consumption
Research-grade vs pharmacy GLP-1s: what the price gap actually buys.
Pens at five figures a month, vials at four figures flat. The honest breakdown of what differs between the two categories, and what does not.
What the pharmacy price includes
A pharmacy incretin pen, Ozempic or Mounjaro on a Philippine shelf, is a finished pharmaceutical. The five-figure monthly cost covers a regulator-approved product manufactured under pharmaceutical GMP, a pre-filled device that delivers fixed doses, a prescription written by a physician, and a pharmacist dispensing it. Every layer of that chain carries accountability, and every layer is in the price. For a patient, that chain is the product. None of it is decoration.
What a research vial is and is not
A research vial is the raw compound: lyophilized powder in a batch-numbered vial, supplied strictly for laboratory research under Research Use Only terms. No approval, no device, no prescriber, no pharmacist. Preparation is manual, by reconstitution with bacteriostatic water, and the buyer carries the entire responsibility the pharmacy chain would otherwise hold. That is the honest trade behind the price gap. What the research route does offer locally: retatrutide 10mg at ₱2,790, or ₱2,510 first order, in stock, and tirzepatide 10mg at ₱2,500, or ₱2,250 first order. It also offers a compound no pharmacy can sell at any price: retatrutide has no approved product anywhere and exists only as a research chemical.
The comparison, itemized
| Dimension | Pharmacy pen | Research vial |
|---|---|---|
| Status | Approved pharmaceutical | Research Use Only chemical |
| Form | Pre-filled fixed-dose pen | Lyophilized powder, manual preparation |
| Access | Prescription, pharmacy dispensing | WhatsApp order, 18+ verification and review |
| Typical cost | Five figures monthly | ₱2,250 to ₱2,790 per 10mg vial |
What does not differ is the molecule class being studied: the same incretin biology, documented in SURMOUNT-1 (NEJM 2022) for tirzepatide and the Phase 2 retatrutide trial (Jastreboff et al., NEJM 2023), drives interest in both markets. The categories exist for different purposes, and the peso gap reflects that purpose gap. Buyers weighing the two should read the prescription question first.
Supplied for laboratory research use only. Not for human consumption. Nothing on this page is medical advice.
Research vs pharmacy questions
What is the actual difference between a pharmacy pen and a research vial?
Regulatory status, presentation and channel. A pharmacy pen is an approved finished drug: fixed doses in a delivery device, dispensed by prescription. A research vial is lyophilized raw compound supplied for laboratory use only, with no approval, no device and no prescription pathway.
How big is the price gap in the Philippines?
Pharmacy incretin pens run to five figures in pesos per month of use. Research vials in the Primara Labs catalogue run ₱2,250 to ₱2,790 per 10mg vial depending on compound and first-order discount. It is a category gap, not a discount.
Which GLP-1 class compounds are available as research vials locally?
The Primara Labs catalogue carries tirzepatide 10mg at ₱2,500, or ₱2,250 first order, and retatrutide 10mg at ₱2,790, or ₱2,510 first order, in stock. Semaglutide is pharmacy-only in the Philippines.
Does a research vial come with a prescription or dosing guidance?
No. Research compounds are supplied for laboratory work under Research Use Only terms, with 18+ verification and order review. There is no prescriber, no dosing guidance and no pharmacist in the chain, which is part of what the pharmacy price pays for.